US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.72

+0.280019.44%

Post-market: 1.68-0.0400-2.33%19:47 EDT

Volume:508.10K

Turnover:832.82K

Market Cap:11.45M

PE:-0.36

High:1.79

Open:1.46

Low:1.40

Close:1.44

52wk High:12.56

52wk Low:0.6201

Shares:6.66M

Float Shares:5.84M

Volume Ratio:2.62

T/O Rate:8.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.7656

EPS(LYR):-8.3501

ROE:-660.08%

ROA:-95.77%

PB:2.47

PE(LYR):-0.21

Loading ...

Overview Company News Filings

FibroBiologics enters $6.15 million at-the-market equity offering agreement with H.C. Wainwright

Fibrobiologics Inc - Enters Atm Offering Agreement to Sell up to $6.15 Mln of Common Stock - SEC Filing

THOMSON REUTERS

FibroBiologics reports Q1 net loss roughly ($5M)

FibroBiologics, Inc. - Common Stock Q1 EPS $(1.33), Inline

Benzinga Earnings

FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update

Fibrobiologics Q1 net loss widens to $5 million; R&D expense climbs to $2.95 million

FibroBiologics to present CYPS317 psoriasis preclinical data at Society for Investigative Dermatology meeting

FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026

FibroBiologics Secures Nasdaq Listing Compliance, Under Monitoring

Fibrobiologics Compliant With All Nasdaq Listing Requirements

THOMSON REUTERS

FibroBiologics Compliant with All Nasdaq Listing Requirements

FibroBiologics Lowers Quorum Requirement in Amended Bylaws

FibroBiologics cuts shareholder meeting quorum requirement to one-third voting power

FibroBiologics Is Maintained at Buy by HC Wainwright & Co.

FibroBiologics target adjusted to $8 at H.C. Wainwright after reverse split

Fibrobiologics, Inc. : H.c. Wainwright Raises Target Price to $8 From $4

THOMSON REUTERS

FibroBiologics presents preclinical thymus organoid data targeting age-related immune decline

BRIEF-Fibrobiologics Inc - Enters Lease Termination Agreement With United Fire & Casualty On April 3, 2026 - SEC Filing

FibroBiologics amends 8-K to add omitted item on sublease termination

FibroBiologics Ends Texas Sublease, Consolidates Houston Operations

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/FBLG/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBLG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":1.72,"timestamp":1788206400000,"preClose":1.44,"halted":0,"volume":508098,"hourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.72,"latestTime":"19:47 EDT","volume":66591,"amount":113663.4873,"timestamp":1788220048777,"change":-0.04,"changeRate":-0.023256,"amplitude":0.05814},"delay":0,"changeRate":0.19444444444444448,"floatShares":5843116,"shares":6658193,"eps":-4.765638,"marketStatus":"Not Yet Opened","change":0.28,"latestTime":"08-31 16:00:00 EDT","open":1.46,"high":1.7899,"low":1.401,"amount":832819.9767336,"amplitude":0.270069,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.765638,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":1.44,"preHourTrading":{"tag":"盘前","latestPrice":1.4239,"preClose":1.44,"latestTime":"09:12 EDT","volume":459,"amount":652.9513221,"timestamp":1788181939256,"change":-0.0161,"changeRate":-0.011181,"amplitude":0.018125},"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.72,"latestTime":"19:47 EDT","volume":66591,"amount":113663.4873,"timestamp":1788220048777,"change":-0.04,"changeRate":-0.023256,"amplitude":0.05814},"volumeRatio":2.617599},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","floatShares":5843116,"roa":"-95.77%","roe":"-660.08%","lyrEps":-8.3501,"volumeRatio":2.617599,"shares":6658193,"dividePrice":0,"high":1.7899,"amplitude":0.270069,"preClose":1.44,"low":1.401,"week52Low":0.62005,"pbRate":"2.47","week52High":12.564,"institutionHeld":0,"latestPrice":1.72,"eps":-4.765638,"divideRate":0,"volume":508098,"delay":0,"ttmEps":-4.765638,"open":1.46,"prevYearClose":4.498,"prevWeekClose":1.44,"prevMonthClose":0.7,"prevQuarterClose":0.9477,"fiveDayClose":1.35,"twentyDayClose":0.7905,"sixtyDayClose":1.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBLG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-31","symbol":"FBLG","fiscalQuarterEnding":"2026/06","expectedEps":-0.93,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785470400000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-04-30","symbol":"FBLG","fiscalQuarterEnding":"2026/03","expectedEps":-1.26,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"post","actualEps":-1.33},{"market":"US","date":"2026-03-30","symbol":"FBLG","defaultRemindTime":1774877400000,"type":"split","dateTimestamp":1774843200000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2026-02-24","symbol":"FBLG","fiscalQuarterEnding":"2025/12","expectedEps":-0.09,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2025-10-31","symbol":"FBLG","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761883200000,"reportTimeType":"post","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBLG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBLG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1778126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FBLG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FBLG","date":"2026-08-28","current":-0.360917,"percent":0.8352,"low":-68.573467,"twenty":-5.885273,"median":-2.888543,"eighty":-0.871962,"high":-0.181252,"avg":-5.846169,"sd":9.565019,"marketCap":9920707},"quantilePoints":[{"date":"2024-02-02","current":-68.573467,"twenty":-68.573467,"median":-68.573467,"eighty":-68.573467,"marketCap":568611190},{"date":"2024-02-09","current":-30.642544,"twenty":-58.777258,"median":-48.452053,"eighty":-34.01244,"marketCap":254087971},{"date":"2024-02-16","current":-50.313332,"twenty":-58.777258,"median":-50.313332,"eighty":-30.642544,"marketCap":417198153},{"date":"2024-02-23","current":-47.413654,"twenty":-56.896385,"median":-48.5892,"eighty":-33.338461,"marketCap":393154022},{"date":"2024-03-01","current":-25.741365,"twenty":-54.984165,"median":-48.491237,"eighty":-33.338461,"marketCap":424346408},{"date":"2024-03-08","current":-19.47356,"twenty":-53.244359,"median":-47.492024,"eighty":-25.717713,"marketCap":321021631},{"date":"2024-03-15","current":-20.892685,"twenty":-51.363486,"median":-37.245189,"eighty":-20.955758,"marketCap":344415920},{"date":"2024-03-22","current":-23.849198,"twenty":-50.446561,"median":-28.99678,"eighty":-20.813845,"marketCap":393154022},{"date":"2024-03-28","current":-23.159345,"twenty":-50.219289,"median":-25.741365,"eighty":-20.93999,"marketCap":381781799},{"date":"2024-04-05","current":-22.469492,"twenty":-49.216157,"median":-24.637601,"eighty":-21.160743,"marketCap":370409575},{"date":"2024-04-12","current":-22.311811,"twenty":-48.471645,"median":-23.652097,"eighty":-21.298713,"marketCap":367810209},{"date":"2024-04-19","current":-21.700799,"twenty":-48.064123,"median":-23.20862,"eighty":-21.030656,"marketCap":357737668},{"date":"2024-04-26","current":-23.021374,"twenty":-47.63309,"median":-22.804563,"eighty":-21.030656,"marketCap":379507354},{"date":"2024-05-03","current":-13.245174,"twenty":-47.445002,"median":-22.479347,"eighty":-20.675875,"marketCap":218346696},{"date":"2024-05-10","current":-17.22661,"twenty":-43.252224,"median":-22.05558,"eighty":-19.871704,"marketCap":283980674},{"date":"2024-05-17","current":-17.017594,"twenty":-36.598639,"median":-21.769784,"eighty":-19.221271,"marketCap":383406402},{"date":"2024-05-24","current":-16.310932,"twenty":-31.990502,"median":-21.661379,"eighty":-18.255477,"marketCap":367485289},{"date":"2024-05-31","current":-17.767522,"twenty":-29.984238,"median":-21.543118,"eighty":-17.827098,"marketCap":400302277},{"date":"2024-06-07","current":-14.972667,"twenty":-28.19741,"median":-21.306597,"eighty":-17.252609,"marketCap":337334178},{"date":"2024-06-14","current":-10.427133,"twenty":-26.746956,"median":-21.178482,"eighty":-16.659936,"marketCap":234923317},{"date":"2024-06-21","current":-7.769521,"twenty":-25.741365,"median":-20.932105,"eighty":-16.368618,"marketCap":175047318},{"date":"2024-06-28","current":-6.767471,"twenty":-25.694061,"median":-20.88283,"eighty":-16.302279,"marketCap":152471122},{"date":"2024-07-05","current":-6.143005,"twenty":-25.43783,"median":-20.64631,"eighty":-15.81876,"marketCap":138401898},{"date":"2024-07-12","current":-7.689204,"twenty":-24.673079,"median":-20.183123,"eighty":-14.136173,"marketCap":173237756},{"date":"2024-07-15","current":-7.514809,"twenty":-24.649427,"median":-20.094427,"eighty":-13.517924,"marketCap":169308652},{"date":"2024-08-02","current":-7.974576,"twenty":-24.625775,"median":-20.005732,"eighty":-13.175194,"marketCap":179667198},{"date":"2024-08-09","current":-4.080921,"twenty":-24.140907,"median":-19.700225,"eighty":-10.836667,"marketCap":79459622},{"date":"2024-08-16","current":-2.166861,"twenty":-23.730937,"median":-18.842837,"eighty":-9.439605,"marketCap":42190950},{"date":"2024-08-23","current":-2.546062,"twenty":-23.640271,"median":-18.638558,"eighty":-7.79743,"marketCap":49574366},{"date":"2024-08-30","current":-2.915474,"twenty":-23.407692,"median":-18.172694,"eighty":-7.552859,"marketCap":56767191},{"date":"2024-09-06","current":-3.368187,"twenty":-23.218475,"median":-17.767522,"eighty":-6.924314,"marketCap":65581972},{"date":"2024-09-13","current":-5.722296,"twenty":-23.104157,"median":-17.428613,"eighty":-6.143005,"marketCap":111418835},{"date":"2024-09-20","current":-5.722296,"twenty":-22.93465,"median":-17.22661,"eighty":-5.90745,"marketCap":111418835},{"date":"2024-09-27","current":-5.686079,"twenty":-22.765143,"median":-16.563311,"eighty":-5.873037,"marketCap":110713652},{"date":"2024-10-04","current":-4.798761,"twenty":-22.619289,"median":-16.368618,"eighty":-5.722296,"marketCap":93436681},{"date":"2024-10-11","current":-4.20118,"twenty":-22.481318,"median":-16.080185,"eighty":-5.265962,"marketCap":81801170},{"date":"2024-10-18","current":-6.012033,"twenty":-22.40642,"median":-15.807485,"eighty":-5.066768,"marketCap":117060295},{"date":"2024-10-25","current":-5.215258,"twenty":-22.209319,"median":-15.237992,"eighty":-5.131958,"marketCap":101546280},{"date":"2024-10-31","current":-5.342017,"twenty":-22.020102,"median":-13.586112,"eighty":-5.110228,"marketCap":104014418},{"date":"2024-11-08","current":-6.464746,"twenty":-21.866364,"median":-12.649071,"eighty":-5.128337,"marketCap":125875076},{"date":"2024-11-15","current":-5.477931,"twenty":-21.799349,"median":-10.768411,"eighty":-5.146445,"marketCap":97392141},{"date":"2024-11-22","current":-4.698155,"twenty":-21.716567,"median":-9.773622,"eighty":-5.018763,"marketCap":83528491},{"date":"2024-11-29","current":-5.107537,"twenty":-21.700799,"median":-9.003931,"eighty":-5.016064,"marketCap":90806907},{"date":"2024-12-06","current":-4.639671,"twenty":-21.661379,"median":-7.895306,"eighty":-4.997955,"marketCap":82488717},{"date":"2024-12-13","current":-4.425233,"twenty":-21.562828,"median":-7.720912,"eighty":-4.979847,"marketCap":78676213},{"date":"2024-12-20","current":-3.957367,"twenty":-21.543118,"median":-7.546517,"eighty":-4.853087,"marketCap":70358023},{"date":"2024-12-27","current":-4.50321,"twenty":-21.511582,"median":-7.203145,"eighty":-4.778145,"marketCap":80062578},{"date":"2025-01-03","current":-3.869642,"twenty":-21.385437,"median":-6.905845,"eighty":-4.698155,"marketCap":68798363},{"date":"2025-01-10","current":-4.065278,"twenty":-21.306597,"median":-6.609614,"eighty":-4.652603,"marketCap":72276579},{"date":"2025-01-17","current":-3.769263,"twenty":-21.298713,"median":-6.286711,"eighty":-4.50321,"marketCap":67013721},{"date":"2025-01-24","current":-3.157497,"twenty":-21.243525,"median":-6.193118,"eighty":-4.433031,"marketCap":56137148},{"date":"2025-01-31","current":-3.295638,"twenty":-21.050366,"median":-6.140899,"eighty":-4.36675,"marketCap":58593149},{"date":"2025-02-07","current":-3.157497,"twenty":-20.955758,"median":-6.004281,"eighty":-4.203103,"marketCap":56137148},{"date":"2025-02-14","current":-2.545732,"twenty":-20.888743,"median":-5.948653,"eighty":-4.068407,"marketCap":45260576},{"date":"2025-02-21","current":-2.447061,"twenty":-20.872975,"median":-5.908467,"eighty":-3.946872,"marketCap":43506290},{"date":"2025-02-28","current":-2.348389,"twenty":-20.794135,"median":-5.885273,"eighty":-3.784683,"marketCap":41752004},{"date":"2025-03-07","current":-2.210248,"twenty":-20.498484,"median":-5.867165,"eighty":-3.670591,"marketCap":39296004},{"date":"2025-03-14","current":-2.109947,"twenty":-20.183123,"median":-5.776622,"eighty":-3.453513,"marketCap":37512750},{"date":"2025-03-21","current":-2.151728,"twenty":-20.183123,"median":-5.722296,"eighty":-3.368187,"marketCap":38255577},{"date":"2025-03-28","current":-2.130838,"twenty":-20.005732,"median":-5.595537,"eighty":-3.295638,"marketCap":37884163},{"date":"2025-04-04","current":-2.958372,"twenty":-19.926892,"median":-5.518575,"eighty":-3.165965,"marketCap":33018387},{"date":"2025-04-11","current":-2.748074,"twenty":-19.788921,"median":-5.342017,"eighty":-3.105834,"marketCap":30671251},{"date":"2025-04-17","current":-3.685286,"twenty":-19.647008,"median":-5.282987,"eighty":-3.104326,"marketCap":41131477},{"date":"2025-04-25","current":-4.361485,"twenty":-19.501154,"median":-5.215258,"eighty":-3.131377,"marketCap":48678537},{"date":"2025-05-02","current":-3.496805,"twenty":-18.968982,"median":-5.142823,"eighty":-3.15355,"marketCap":39027837},{"date":"2025-05-09","current":-2.900977,"twenty":-18.732461,"median":-5.107537,"eighty":-3.105179,"marketCap":32377800},{"date":"2025-05-16","current":-5.090366,"twenty":-18.693381,"median":-5.090366,"eighty":-3.095239,"marketCap":39027837},{"date":"2025-05-23","current":-4.291877,"twenty":-18.607387,"median":-5.049055,"eighty":-3.101704,"marketCap":32905823},{"date":"2025-05-30","current":-3.742916,"twenty":-18.421041,"median":-5.00701,"eighty":-3.104523,"marketCap":28696939},{"date":"2025-06-06","current":-4.262932,"twenty":-18.227882,"median":-4.979847,"eighty":-3.124991,"marketCap":32683900},{"date":"2025-06-13","current":-4.354259,"twenty":-18.018955,"median":-4.934576,"eighty":-3.149603,"marketCap":33384106},{"date":"2025-06-20","current":-3.674878,"twenty":-17.856887,"median":-4.868731,"eighty":-3.157497,"marketCap":28175292},{"date":"2025-06-27","current":-3.644169,"twenty":-17.748258,"median":-4.815121,"eighty":-3.160884,"marketCap":27939844},{"date":"2025-07-03","current":-3.132347,"twenty":-17.688614,"median":-4.795627,"eighty":-3.157497,"marketCap":24015708},{"date":"2025-07-11","current":-3.321721,"twenty":-17.510817,"median":-4.711647,"eighty":-3.13343,"marketCap":25467638},{"date":"2025-07-18","current":-3.531568,"twenty":-17.278608,"median":-4.698155,"eighty":-3.14171,"marketCap":27076534},{"date":"2025-07-25","current":-3.36062,"twenty":-17.22661,"median":-4.675331,"eighty":-3.157497,"marketCap":25765873},{"date":"2025-08-01","current":-3.260303,"twenty":-17.184807,"median":-4.665775,"eighty":-3.157497,"marketCap":24996742},{"date":"2025-08-08","current":-1.692292,"twenty":-16.92818,"median":-4.639671,"eighty":-3.111465,"marketCap":22377179},{"date":"2025-08-15","current":-1.862725,"twenty":-16.567638,"median":-4.558872,"eighty":-3.098103,"marketCap":24630815},{"date":"2025-08-22","current":-1.865576,"twenty":-16.533025,"median":-4.524553,"eighty":-3.074912,"marketCap":24668515},{"date":"2025-08-29","current":-1.964732,"twenty":-16.426305,"median":-4.50321,"eighty":-3.015849,"marketCap":25979645},{"date":"2025-09-05","current":-1.881416,"twenty":-16.368618,"median":-4.425233,"eighty":-2.962429,"marketCap":24877961},{"date":"2025-09-12","current":-1.789547,"twenty":-16.310932,"median":-4.376497,"eighty":-2.933582,"marketCap":23663176},{"date":"2025-09-19","current":-1.694826,"twenty":-16.29651,"median":-4.361485,"eighty":-2.897365,"marketCap":22410690},{"date":"2025-09-26","current":-1.709716,"twenty":-15.863859,"median":-4.348021,"eighty":-2.853034,"marketCap":22607569},{"date":"2025-10-03","current":-1.710666,"twenty":-15.863859,"median":-4.327761,"eighty":-2.748074,"marketCap":22620136},{"date":"2025-10-10","current":-1.544034,"twenty":-15.807485,"median":-4.261494,"eighty":-2.486529,"marketCap":20416767},{"date":"2025-10-17","current":-1.298839,"twenty":-15.630094,"median":-4.210794,"eighty":-2.348389,"marketCap":17174548},{"date":"2025-10-24","current":-1.301056,"twenty":-15.503317,"median":-4.186877,"eighty":-2.318853,"marketCap":17203870},{"date":"2025-10-31","current":-1.257339,"twenty":-14.972667,"median":-4.132817,"eighty":-2.297962,"marketCap":16625800},{"date":"2025-11-07","current":-0.932278,"twenty":-13.927049,"median":-4.072247,"eighty":-2.249717,"marketCap":17248077},{"date":"2025-11-14","current":-0.933669,"twenty":-13.245174,"median":-4.04235,"eighty":-2.172619,"marketCap":17273805},{"date":"2025-11-21","current":-0.902797,"twenty":-13.070223,"median":-4.004863,"eighty":-2.130838,"marketCap":16702642},{"date":"2025-11-28","current":-0.907742,"twenty":-12.733301,"median":-3.95212,"eighty":-2.105769,"marketCap":16794130},{"date":"2025-12-05","current":-0.861361,"twenty":-11.417566,"median":-3.918378,"eighty":-2.038689,"marketCap":15936036},{"date":"2025-12-12","current":-1.151904,"twenty":-11.10969,"median":-3.880347,"eighty":-1.962831,"marketCap":21311383},{"date":"2025-12-19","current":-0.864342,"twenty":-10.563644,"median":-3.855551,"eighty":-1.925449,"marketCap":15991199},{"date":"2025-12-26","current":-0.781519,"twenty":-10.366139,"median":-3.817676,"eighty":-1.905048,"marketCap":14458888},{"date":"2026-01-02","current":-0.80862,"twenty":-10.104734,"median":-3.784683,"eighty":-1.867667,"marketCap":14960285},{"date":"2026-01-09","current":-1.186504,"twenty":-9.756195,"median":-3.726488,"eighty":-1.863485,"marketCap":21951508},{"date":"2026-01-16","current":-1.21347,"twenty":-9.439605,"median":-3.689721,"eighty":-1.817994,"marketCap":22450406},{"date":"2026-01-23","current":-1.222459,"twenty":-8.832939,"median":-3.685286,"eighty":-1.804182,"marketCap":22616705},{"date":"2026-01-30","current":-1.226773,"twenty":-8.114091,"median":-3.670176,"eighty":-1.745069,"marketCap":22696529},{"date":"2026-02-06","current":-0.81653,"twenty":-7.942868,"median":-3.64061,"eighty":-1.71998,"marketCap":15106628},{"date":"2026-02-13","current":-0.884485,"twenty":-7.806733,"median":-3.5628,"eighty":-1.705851,"marketCap":16363851},{"date":"2026-02-20","current":-0.903181,"twenty":-7.769521,"median":-3.544415,"eighty":-1.692292,"marketCap":16709754},{"date":"2026-02-27","current":-1.025558,"twenty":-7.720912,"median":-3.492982,"eighty":-1.665999,"marketCap":19122546},{"date":"2026-03-06","current":-1.519667,"twenty":-7.689204,"median":-3.463009,"eighty":-1.553538,"marketCap":28335707},{"date":"2026-03-13","current":-1.232917,"twenty":-7.578225,"median":-3.43637,"eighty":-1.519667,"marketCap":22988964},{"date":"2026-03-20","current":-0.927678,"twenty":-7.514809,"median":-3.414459,"eighty":-1.43094,"marketCap":17297489},{"date":"2026-03-27","current":-0.797535,"twenty":-7.246713,"median":-3.39431,"eighty":-1.385333,"marketCap":14870838},{"date":"2026-04-02","current":-0.241073,"twenty":-7.177005,"median":-3.378022,"eighty":-1.359957,"marketCap":4495048},{"date":"2026-04-10","current":-0.336129,"twenty":-7.067291,"median":-3.359084,"eighty":-1.328997,"marketCap":6267453},{"date":"2026-04-17","current":-0.370229,"twenty":-6.822821,"median":-3.321721,"eighty":-1.299599,"marketCap":6903282},{"date":"2026-04-24","current":-0.367793,"twenty":-6.742593,"median":-3.30892,"eighty":-1.267223,"marketCap":6857865},{"date":"2026-05-01","current":-0.368753,"twenty":-6.533559,"median":-3.275657,"eighty":-1.232416,"marketCap":6875767},{"date":"2026-05-08","current":-0.345774,"twenty":-6.468368,"median":-3.258236,"eighty":-1.221308,"marketCap":6459054},{"date":"2026-05-15","current":-0.312154,"twenty":-6.322318,"median":-3.235952,"eighty":-1.201893,"marketCap":5831040},{"date":"2026-05-22","current":-0.303483,"twenty":-6.255297,"median":-3.19076,"eighty":-1.171044,"marketCap":5669067},{"date":"2026-05-29","current":-0.326606,"twenty":-6.214848,"median":-3.171598,"eighty":-1.119059,"marketCap":6100996},{"date":"2026-06-05","current":-0.309264,"twenty":-6.16305,"median":-3.157497,"eighty":-1.023143,"marketCap":5777049},{"date":"2026-06-12","current":-0.278626,"twenty":-6.143005,"median":-3.135055,"eighty":-0.995266,"marketCap":5204743},{"date":"2026-06-18","current":-0.231225,"twenty":-6.14132,"median":-3.119296,"eighty":-0.966672,"marketCap":4319289},{"date":"2026-06-26","current":-0.211918,"twenty":-6.088089,"median":-3.102557,"eighty":-0.949468,"marketCap":3958628},{"date":"2026-07-02","current":-0.261949,"twenty":-6.010483,"median":-3.098055,"eighty":-0.939027,"marketCap":4893215},{"date":"2026-07-10","current":-0.248856,"twenty":-6.001989,"median":-3.08079,"eighty":-0.932373,"marketCap":4648635},{"date":"2026-07-17","current":-0.242729,"twenty":-5.989422,"median":-3.058826,"eighty":-0.919078,"marketCap":4534174},{"date":"2026-07-24","current":-0.212583,"twenty":-5.964951,"median":-3.025992,"eighty":-0.912766,"marketCap":3971046},{"date":"2026-07-31","current":-0.207872,"twenty":-5.92149,"median":-2.981001,"eighty":-0.907742,"marketCap":3883041},{"date":"2026-08-07","current":-0.374406,"twenty":-5.913552,"median":-2.958372,"eighty":-0.904979,"marketCap":6791356},{"date":"2026-08-14","current":-0.422125,"twenty":-5.903382,"median":-2.937355,"eighty":-0.902462,"marketCap":7656921},{"date":"2026-08-21","current":-0.473514,"twenty":-5.885273,"median":-2.907657,"eighty":-0.890492,"marketCap":8589068},{"date":"2026-08-28","current":-0.546927,"twenty":-5.885273,"median":-2.888543,"eighty":-0.871962,"marketCap":9920707}],"updateTime":1788235871120},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBLG\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632642269","title":"FibroBiologics enters $6.15 million at-the-market equity offering agreement with H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2632642269","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632642269?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:02","pubTimestamp":1777665747,"startTime":"0","endTime":"0","summary":"FibroBiologics entered at-the-market offering agreement with H.C. Wainwright to sell up to USD 6.15 million of common stock.Net proceeds expected to support working capital needs or general corporate purposes.Sales agent to receive 3% of gross sales proceeds.Company agreed to reimburse up to USD 100,000 of legal fees tied to agreement setup.Program can end once full USD 6.15 million is sold or if sales agreement is terminated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL6kG9rT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632642256","title":"Fibrobiologics Inc - Enters Atm Offering Agreement to Sell up to $6.15 Mln of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2632642256","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632642256?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:02","pubTimestamp":1777665735,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nFWN41D1U9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632666277","title":"FibroBiologics reports Q1 net loss roughly ($5M)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632666277","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632666277?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:00","pubTimestamp":1777586427,"startTime":"0","endTime":"0","summary":"The net loss for the three months ended March 31, 2026, was primarily due to research and development expenses and general and administrative expen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-reports-q1-net-loss-roughly-5m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-reports-q1-net-loss-roughly-5m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632662236","title":"FibroBiologics, Inc. - Common Stock Q1 EPS $(1.33), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2632662236","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632662236?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:57","pubTimestamp":1777586270,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. - Common Stock Q1 EPS $(1.33), Inline","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/FBLG","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"FibroBiologics, Inc. - Common Stock Q1 EPS $(1.33), Inline","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632622646","title":"FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2632622646","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632622646?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:55","pubTimestamp":1777586100,"startTime":"0","endTime":"0","summary":"On track for first patient dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers in Q2 of 2026HOUSTON, April  30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3285584/0/en/FibroBiologics-Reports-Q1-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632460662","title":"Fibrobiologics Q1 net loss widens to $5 million; R&D expense climbs to $2.95 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632460662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632460662?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:53","pubTimestamp":1777586022,"startTime":"0","endTime":"0","summary":"Fibrobiologics posted a net loss of USD 5 million for the three months ended March 31, 2026.Research and development expense climbed to USD 2.95 million, while general, administrative and other costs fell to USD 2.12 million.Cash and cash equivalents totaled USD 1.5 million as of March 31, 2026, with net cash used in operating activities of USD 4.36 million.Pipeline update: CYWC628 diabetic foot ulcer Phase 1/2 trial in Australia expected to start screening, enrollment and dosing in Q2 2026, with interim data expected in Q3 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system opera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL7dtNsR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631371886","title":"FibroBiologics to present CYPS317 psoriasis preclinical data at Society for Investigative Dermatology meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631371886","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631371886?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:45","pubTimestamp":1777553141,"startTime":"0","endTime":"0","summary":"FibroBiologics will present preclinical data from CYPS317 psoriasis program at Society for Investigative Dermatology 2026 Annual Meeting in Chicago on May 13-15, 2026.Poster session is scheduled for May 15, 2026, 4:30 p.m.-6 p.m. CT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLc4Twz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631986637","title":"FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631986637","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631986637?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:30","pubTimestamp":1777552200,"startTime":"0","endTime":"0","summary":"HOUSTON, April  30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284850/0/en/FibroBiologics-Announces-Poster-Presentation-at-the-Society-for-Investigative-Dermatology-Annual-Meeting-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629674779","title":"FibroBiologics Secures Nasdaq Listing Compliance, Under Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2629674779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629674779?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:00","pubTimestamp":1776718807,"startTime":"0","endTime":"0","summary":"An update from FibroBiologics, Inc. ( ($FBLG) ) is now available. On April 20, 2026, FibroBiologics announced that Nasdaq confirmed the company has...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-secures-nasdaq-listing-compliance-under-monitoring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-secures-nasdaq-listing-compliance-under-monitoring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629775634","title":"Fibrobiologics Compliant With All Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2629775634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629775634?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:01","pubTimestamp":1776715260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nTUA6BD62W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629206775","title":"FibroBiologics Compliant with All Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2629206775","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629206775?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:01","pubTimestamp":1776715260,"startTime":"0","endTime":"0","summary":"HOUSTON, April  20, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the dev","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3277440/0/en/FibroBiologics-Compliant-with-All-Nasdaq-Listing-Requirements.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628378263","title":"FibroBiologics Lowers Quorum Requirement in Amended Bylaws","url":"https://stock-news.laohu8.com/highlight/detail?id=2628378263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628378263?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:43","pubTimestamp":1776458637,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. ( ($FBLG) ) has issued an announcement. On April 16, 2026, FibroBiologics, Inc.’s board of directors amended and restated the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-lowers-quorum-requirement-in-amended-bylaws?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-lowers-quorum-requirement-in-amended-bylaws?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781238","title":"FibroBiologics cuts shareholder meeting quorum requirement to one-third voting power","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781238?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:06","pubTimestamp":1776456413,"startTime":"0","endTime":"0","summary":"FibroBiologics amended and restated bylaws April 16, 2026 to lower stockholder meeting quorum requirement.Quorum threshold shifted to one-third of voting power from a majority of voting power.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL4pSr9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628167210","title":"FibroBiologics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2628167210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628167210?lang=en_us&edition=fundamental","pubTime":"2026-04-17 01:14","pubTimestamp":1776359640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FBLG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 16, 2026 13:14 ET (17:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627214679","title":"FibroBiologics target adjusted to $8 at H.C. Wainwright after reverse split","url":"https://stock-news.laohu8.com/highlight/detail?id=2627214679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627214679?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:53","pubTimestamp":1776351212,"startTime":"0","endTime":"0","summary":"H.C. Wainwright adjusted the firm’s price target on FibroBiologics (FBLG) to $8 from $4 and keeps a Buy rating on the shares based on the announced...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-target-adjusted-to-8-at-h-c-wainwright-after-reverse-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-target-adjusted-to-8-at-h-c-wainwright-after-reverse-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627121907","title":"Fibrobiologics, Inc. : H.c. Wainwright Raises Target Price to $8 From $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2627121907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627121907?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:23","pubTimestamp":1776349410,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nAZN4SR6Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626903491","title":"FibroBiologics presents preclinical thymus organoid data targeting age-related immune decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2626903491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626903491?lang=en_us&edition=fundamental","pubTime":"2026-04-10 20:32","pubTimestamp":1775824326,"startTime":"0","endTime":"0","summary":"FibroBiologics presented preclinical data at Keystone Symposia on Aging and Immunity for a thymus organoid platform aimed at reversing age-related immune decline.Mouse studies showed transplanted organoids generated functional T cells, supporting potential to restore immune function as thymus activity wanes with age.Separate cancer-model work indicated organoid-derived antigen-specific immune cells slowed tumor growth, suggesting potential oncology applications.Program positioned as a scalable, injectable, cryopreservable organoid product, signaling a potential pipeline expansion beyond fibroblast-based therapeutics.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL2HBk7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","FBLG","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626155339","title":"BRIEF-Fibrobiologics Inc - Enters Lease Termination Agreement With United Fire & Casualty On April 3, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626155339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626155339?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:08","pubTimestamp":1775772511,"startTime":"0","endTime":"0","summary":"BRIEF-Fibrobiologics Inc - Enters Lease Termination Agreement With United Fire & Casualty On April 3, 2026 - SEC FilingApril 9 (Reuters) - Fibrobiologics Inc FBLG.O:FIBROBIOLOGICS INC - ENTERS LEASE T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S1E4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626153630","title":"FibroBiologics amends 8-K to add omitted item on sublease termination","url":"https://stock-news.laohu8.com/highlight/detail?id=2626153630","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626153630?lang=en_us&edition=fundamental","pubTime":"2026-04-10 05:21","pubTimestamp":1775769665,"startTime":"0","endTime":"0","summary":"FibroBiologics filed an amended Form 8-K to add Item 1.02, which was omitted from original April 9 filing.Amendment did not change disclosures from original report.Filing confirms termination of Webster, Texas sublease effective April 2, 2026, via April 3, 2026 lease termination agreement.Company settled remaining rent obligations with single payment of USD 45,108.25, projecting about USD 0.8 million in future rent savings.Principal executive offices address updated to 9350 Kirby Drive, Suite 300, Houston, Texas 77054.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL3Bqd75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626584621","title":"FibroBiologics Ends Texas Sublease, Consolidates Houston Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2626584621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626584621?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:54","pubTimestamp":1775768077,"startTime":"0","endTime":"0","summary":"An update from FibroBiologics, Inc. ( ($FBLG) ) is now available. On April 3, 2026, FibroBiologics, Inc. disclosed that it had entered into a Suble...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-ends-texas-sublease-consolidates-houston-operations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-ends-texas-sublease-consolidates-houston-operations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":130,"code":"91000000","status":"200"}]}}